GABRB2 and schizophrenia: For example, alterations in the GABAA receptor subunit beta2 (GABRB2) have been implicated in several neuropsychiatric and neurodevelopmental disorders, including schizophrenia (SZ), bipolar disorder (BP), frontotemporal dementia (FTD) and ASD [34–41].